MarketInOut Stock Screener Log In | Sign Up
 

Sanofi ADR

NASDAQ • Healthcare • Drug Manufacturers - General • Quote as of 05/22/2026
Sanofi ADR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization105,853 mln
Float1,087 mln
Earnings Date07/30/2026

EPS

2.30
Solid

P / E

19.26
Moderately valued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.45
Borderline

1-Year Forecast

55.90
Strong upside

Relative Strength

79 / 100
Strongly outperforming

Business Description

Sanofi is a Paris-based global pharmaceutical company founded in 1994 that researches, develops, and sells treatments across a wide range of medical areas, including rare diseases, cancer, neurology, and immune conditions, as well as a broad portfolio of vaccines. The company works with numerous partners to advance next-generation therapies, including AI-driven drug discovery, protein degradation treatments, genome editing, and antibody-based medicines. Through these collaborations, Sanofi aims to bring meaningful new treatment options to patients around the world.

Key Fundamentals

EPS2.30
P/E19.26
ROE11.06
RPS22.12
ROIC7.30
ROA6.29
Interest Cover15.34
EBITDA, mln14,513
EV / EBITDA8.73
EV / EBIT16.04
Revenue, mln54,328
EV / Revenue2.33

Financial Strength

Altman Z-Score1.64
Piotroski F-Score 7 / 9
Beneish M-Score-2.45
Price to Intrinsic Value0.75
Price to Graham Number3.59
1-Year Target Price55.90
Shiller PE Ratio13.18
Short Ratio2.89
Short % of Float0.37

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.75% 78 / 100   
1 Month -1.62% 32 / 100   
2 Months 1.63% 53 / 100   
6 Months -5.65% 30 / 100   
1 Year -11.61% 26 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us